enGene Holdings Inc. — Investor Relations & Filings
enGene Holdings Inc. is a clinical-stage biotechnology company developing non-viral gene therapies. The company's proprietary platform is designed for the local delivery of DNA-based immunotherapies directly to mucosal tissues and other organs. Its lead product candidate, EG-70 (detalimogene voraplasmid), is an intravesical therapy being evaluated for the treatment of high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The therapeutic approach aims to stimulate a patient's own immune system to attack tumor cells. By avoiding viral vectors, enGene seeks to create re-dosable genetic medicines that can be administered without the complexities and potential immunogenicity associated with viral-based systems, with the goal of making gene-based treatments more accessible.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-05-07 | English | |
| 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-04-09 | English | |
| S-3 - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | |
| 10-K/A - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42868120 | 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-05-07 | English | ||
| 33934986 | 8-K - enGene Therapeutics Inc. (0001980845) (Filer) | 2026-04-09 | English | ||
| 32900837 | S-3 - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | ||
| 32900836 | 10-K/A - ENGENE HOLDINGS INC. (0001980845) (Filer) | 2026-02-19 | English | ||
| 32274886 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 32274884 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32274835 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32274946 | 4 Filing | 2026-02-03 | English | ||
| 32274937 | 4 Filing | 2026-02-03 | English | ||
| 32274933 | 4 Filing | 2026-02-03 | English | ||
| 32274932 | 4 Filing | 2026-02-03 | English | ||
| 32274917 | 4 Filing | 2026-02-03 | English | ||
| 32274909 | 4 Filing | 2026-02-03 | English | ||
| 32274904 | 4 Filing | 2026-02-03 | English | ||
| 32274832 | 4 Filing | 2026-02-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
enGene Holdings Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33225/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33225 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33225 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33225 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33225}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for enGene Holdings Inc. (id: 33225)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.